Streetbeat News

Partnerships

TU

TELUS has partnered with Vevo to become its direct ad sales representative in Canada, offering advertisers access to Vevo's premium music video content across various platforms. This collaboration aims to provide value for local brands and media agencies by connecting them with audiences through influential music videos, leveraging TELUS' reach in the Canadian market.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 2:18 pm

MC

Moelis & Company (NYSE:MC) announced the appointment of Stephen Trauber as Chairman and Global Head of Energy and Clean Technology, along with the hiring of energy bankers Muhammad Laghari and Alexander Burpee as Managing Directors. This move aims to expand Moelis's global energy franchise, leveraging Trauber's extensive experience in energy transactions and the new hires' expertise. The firm emphasizes its commitment to the energy sector's strategic evolution, including clean technology and energy transition, following the launch of its Clean Technology Group in September 2023.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 2:14 pm

CHPT

WFC

ChargePoint (CHPT), EnTech Solutions, and Wells Fargo (WFC) announced a collaboration to provide simplified, flexible financing solutions for businesses aiming to build out charging infrastructure for EV fleets. The partnership focuses on the eSkid charging solution, a rapidly deployable EV charging platform that utilizes ChargePoint hardware and software, offering an affordable financial package with various term options. This initiative aims to reduce the financial and logistical barriers companies face when installing EV charging infrastructure, promoting sustainability and the growth of electric vehicle utilization.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 2:12 pm

IVDA

Iveda's exclusive distribution partner in Latin America projects FY24 revenue of $6M, with expectations of $30M in recurring revenue over the next five years. This forecast follows a series of efforts and presentations throughout 2023 aimed at establishing Iveda as a leader in AI technology.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 2:10 pm

CORN

EPOL

SOYB

VGK

WEAT

Polish Prime Minister Donald Tusk announced a meeting with protesting farmers to address their concerns over EU regulations, rising costs, and competition from Ukraine. Tusk mentioned discussions with Ukraine about potentially closing the border temporarily to address the influx of food products, which Poland finds problematic due to the war's impact on agriculture.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 2:06 pm

CAH

SCLX

Scilex Holding Company announced that its anti-gout medication, GLOPERBA®, will be stocked in leading national pharmacy chains across the U.S. ahead of its expected launch in the first half of 2024. The company is also negotiating with additional chains for stocking arrangements. GLOPERBA®, the first liquid oral colchicine for gout prophylaxis, targets the growing gout treatment market, projected to reach $2.0 billion by 2028. Scilex has increased GLOPERBA® production, with inventory available at Cardinal Health.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 2:02 pm

TONUSD

Telegram has announced a new revenue-sharing model for content creators, utilizing the TON blockchain for ad revenue transactions. This model allows creators to earn 50% of the revenue from ads displayed within their channels. The move aims to monetize the platform's vast viewership and incentivize high-quality content creation. Following the announcement, TON's price surged by 24.3%, trading at $2.70.

Portfolio Pulse from Murtuza Merchant

February 28, 2024 | 1:56 pm

DYAI

Dyadic International, Inc. (NASDAQ:DYAI) has announced a strategic partnership with Rabian BV to develop affordable rabies vaccines using its C1 protein production platform. The collaboration, supported by Eurostars and the European Union's Horizon Europe, aims to address the global rabies burden, particularly in lower- and middle-income countries. Dyadic will receive an equity stake, fully funded R&D costs, and royalties upon commercialization. This partnership builds on a long-standing collaboration between the two entities, focusing on making preventive vaccination more accessible and cost-effective.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 1:37 pm

INBS

Intelligent Bio Solutions Inc. (INBS) partners with Cliantha Research for a pharmacokinetic study as part of its FDA 510(k) clinical study plan. The study aims to compare opiate levels in fingerprint sweat against traditional specimens, using INBS' Intelligent Fingerprinting Drug Screening System. This marks a significant step in INBS' journey towards FDA approval and U.S. market entry. The FDA has provisionally classified the screening cartridge as a Class II device, requiring 510(k) submission and clearance. The study, starting in May 2024, seeks to validate fingerprint sweat as a reliable testing method for opiates.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 1:35 pm

MLSS

Milestone Scientific has initiated direct sales of its STA Single Tooth Anesthesia System through a partnership with Meridian Endo & Perio. This move marks a significant step for Milestone Scientific (MLSS) in expanding its market presence and directly engaging with its customer base.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 1:34 pm